Nociti, Viviana
 Distribuzione geografica
Continente #
EU - Europa 4.013
NA - Nord America 3.675
AS - Asia 1.488
SA - Sud America 341
AF - Africa 33
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 9.570
Nazione #
US - Stati Uniti d'America 3.642
DE - Germania 1.656
SE - Svezia 739
CN - Cina 568
SG - Singapore 485
UA - Ucraina 346
BR - Brasile 302
FR - Francia 282
IT - Italia 268
IE - Irlanda 168
GB - Regno Unito 160
FI - Finlandia 140
IN - India 119
ID - Indonesia 109
RU - Federazione Russa 86
TR - Turchia 56
PL - Polonia 39
BE - Belgio 34
VN - Vietnam 23
JP - Giappone 21
CA - Canada 20
IR - Iran 19
AT - Austria 18
NL - Olanda 18
CI - Costa d'Avorio 15
HK - Hong Kong 15
KR - Corea 15
AU - Australia 10
IQ - Iraq 10
AR - Argentina 7
CL - Cile 7
ES - Italia 7
ZA - Sudafrica 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AZ - Azerbaigian 6
CH - Svizzera 6
CO - Colombia 6
EC - Ecuador 6
IL - Israele 6
RO - Romania 6
CZ - Repubblica Ceca 5
MX - Messico 5
BD - Bangladesh 4
BG - Bulgaria 4
MA - Marocco 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
VE - Venezuela 4
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
PT - Portogallo 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
Totale 9.570
Città #
Chandler 758
Ashburn 315
Singapore 293
Jacksonville 246
Ann Arbor 191
San Mateo 178
Dublin 168
Munich 139
Nürnberg 116
Nanjing 115
Jakarta 109
Wilmington 105
New York 103
Dearborn 101
Woodbridge 77
Houston 63
Princeton 62
Boston 61
Helsinki 58
Moscow 54
Marseille 50
Los Angeles 49
Milan 46
Bremen 45
Izmir 44
Redwood City 43
Norwalk 42
Beijing 41
Nanchang 41
Seattle 41
Lawrence 35
Brussels 33
Cattolica 32
Chicago 31
Fairfield 29
Rome 29
Hefei 28
Detroit 27
Frankfurt am Main 24
Kraków 24
Mountain View 24
Kunming 23
Shanghai 23
Hebei 22
University Park 22
Shenyang 21
São Paulo 21
Boardman 20
Düsseldorf 20
Jiaxing 19
Tianjin 18
Guangzhou 16
Nuremberg 16
Abidjan 15
Fremont 15
Hong Kong 15
Seoul 15
Portsmouth 14
Leawood 13
Hanoi 12
Ottawa 12
Redmond 12
Zhengzhou 12
Changsha 11
Falls Church 11
Pune 11
Belo Horizonte 10
Rio de Janeiro 10
Hangzhou 9
London 9
Vienna 9
Warsaw 9
Bexley 8
Brooklyn 8
Fairport 8
Jinan 8
North Bergen 8
Santa Clara 8
Simi Valley 8
Verona 8
Florence 7
Ho Chi Minh City 7
Indiana 7
Lauterbourg 7
Newark 7
Turku 7
Baku 6
Campinas 6
Changchun 6
Dallas 6
Edinburgh 6
Falkenstein 6
Johannesburg 6
Kansas City 6
Melbourne 6
Roubaix 6
San Francisco 6
Washington 6
Buffalo 5
Fuzhou 5
Totale 4.723
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 219
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 213
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 192
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 175
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 175
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 174
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 165
Multiple Sclerosis attacks triggered by hyperprolactinemia 159
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 155
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 149
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? 143
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 143
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 139
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 136
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 135
A Case of Hemiabdominal Myoclonus 134
Migraine-like headache and status migrainosus as attacks of Multiple Sclerosis in a child. 132
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 128
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 128
Pneumonia's link with the head and heart. 126
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 122
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 121
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 120
Movement disorders in multiple sclerosis: Causal or coincidental association? 118
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 116
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 111
Type 1 immune response in progressive Multiple Sclerosis 109
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 107
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 105
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 104
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 102
Serum lactate as a novel potential biomarker in multiple sclerosis 101
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 100
Pneumonia's link with the head and the heart 99
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 99
Tourettism in multiple sclerosis: a case report 98
Chronic migraine-like headache caused by a demyelinating lesion in the brainstem 98
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients 97
Coeliac disease presenting with acute disseminated encephalomyelitis 97
Breastfeeding and multiple sclerosis 97
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 95
Teaching NeuroImages: Autosomal dominant leukodystrophy in a sporadic case. 93
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 90
Multiple sclerosis attacks triggered by hyperprolactinemia 88
A Case of Hemiabdominal Myoclonus 88
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 88
Case of postpartum Parsonage-Turner syndrome 87
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 85
Focal hyperhidrosis in tumefactive Multiple Sclerosis 85
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 85
Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection 85
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 85
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 84
Glioblastoma in multiple sclerosis: a case report 83
Coeliac disease presenting with acute disseminated encephalomyelitis. 82
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 82
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 81
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 81
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 79
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 77
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 76
Fingolimod vs dimethyl fumarate in multiple sclerosis 75
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 75
Clinical characteristics, course and prognosis of spinal multiple sclerosis 74
Posterior reversible encephalopathy syndrome after intramuscular oxygen-ozone therapy 74
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 74
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 73
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 71
A unique case of multiphasic ADEM or what else? 71
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 71
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 71
What do we know about the role of lncRNAs in multiple sclerosis? 70
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 68
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 67
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 67
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 66
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 65
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 64
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 64
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 64
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 62
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 61
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 60
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 60
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 60
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 58
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 57
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 56
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 55
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 54
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 54
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 54
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 53
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 51
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 49
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 45
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 45
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 42
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 42
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study 41
Totale 9.403
Categoria #
all - tutte 41.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 0 0 0 0 0 83
2020/2021824 36 69 24 72 84 44 80 34 90 61 200 30
2021/2022959 98 78 18 120 29 38 17 141 48 55 130 187
2022/20232.007 224 283 164 319 121 276 101 183 233 31 53 19
2023/2024907 35 269 26 59 24 122 92 27 21 24 103 105
2024/20251.806 54 67 145 97 124 85 78 99 321 166 381 189
Totale 9.694